Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hans-Jorg Meisel"'
Rate of Reoperation Following Decompression-Only Procedure for Lumbar Degenerative Spondylolisthesis
Autor:
Sathish Muthu, MS, DNB, MNAMS, Stipe Ćorluka, MD, Zorica Buser, MBA, PhD, James G. Malcolm, MD, PhD, Zhuojing Luo, MD, PhD, Prajwal Gollahalli Shivashankar, MS, Luca Ambrosio, MD, Cristiana Griffoni, PhD, Andreas K. Demetriades, MPhil, FRCSEd(NeuroSurg), FEBNS, Stjepan Ivandić, MD, Yabin Wu, PhD, Jeffrey Wang, MD, Hans-Jorg Meisel, MD, Tim Sangwook Yoon, MD, PhD, FAOA
Publikováno v:
JBJS Open Access, Vol 9, Iss 3 (2024)
Background:. Management of lumbar degenerative spondylolisthesis with decompression-only procedure has been performed for its added benefit of a shorter duration of surgery, lower blood loss, and shorter hospital stay. However, reported failure rates
Externí odkaz:
https://doaj.org/article/82a61975c925458781e943d961ba9b1e
Autor:
Sathish Muthu, Georgios Mavrovounis, Stipe Corluka, Zorica Buser, Giovanni Barbanti Brodano, Yabin Wu, Hans-Jorg Meisel, Jeffrey Wang, S. Tim Yoon, Andreas K. Demetriades
Publikováno v:
Brain and Spine, Vol 3, Iss , Pp 102711- (2023)
Introduction: To date, the available guidance on venous thromboembolism (VTE) prevention in elective lumbar fusion surgery is largely open to surgeon interpretation and preference without any specific suggested chemoprophylactic regimen. Research que
Externí odkaz:
https://doaj.org/article/c2ab6373bbb34590992808b7802d4838
Autor:
Linda M. Liau, Keyoumars Ashkan, David D. Tran, Jian L. Campian, John E. Trusheim, Charles S. Cobbs, Jason A. Heth, Michael Salacz, Sarah Taylor, Stacy D. D’Andre, Fabio M. Iwamoto, Edward J. Dropcho, Yaron A. Moshel, Kevin A. Walter, Clement P. Pillainayagam, Robert Aiken, Rekha Chaudhary, Samuel A. Goldlust, Daniela A. Bota, Paul Duic, Jai Grewal, Heinrich Elinzano, Steven A. Toms, Kevin O. Lillehei, Tom Mikkelsen, Tobias Walbert, Steven R. Abram, Andrew J. Brenner, Steven Brem, Matthew G. Ewend, Simon Khagi, Jana Portnow, Lyndon J. Kim, William G. Loudon, Reid C. Thompson, David E. Avigan, Karen L. Fink, Francois J. Geoffroy, Scott Lindhorst, Jose Lutzky, Andrew E. Sloan, Gabriele Schackert, Dietmar Krex, Hans-Jorg Meisel, Julian Wu, Raphael P. Davis, Christopher Duma, Arnold B. Etame, David Mathieu, Santosh Kesari, David Piccioni, Manfred Westphal, David S. Baskin, Pamela Z. New, Michel Lacroix, Sven-Axel May, Timothy J. Pluard, Victor Tse, Richard M. Green, John L. Villano, Michael Pearlman, Kevin Petrecca, Michael Schulder, Lynne P. Taylor, Anthony E. Maida, Robert M. Prins, Timothy F. Cloughesy, Paul Mulholland, Marnix L. Bosch
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-9 (2018)
Abstract Background Standard therapy for glioblastoma includes surgery, radiotherapy, and temozolomide. This Phase 3 trial evaluates the addition of an autologous tumor lysate-pulsed dendritic cell vaccine (DCVax®-L) to standard therapy for newly di
Externí odkaz:
https://doaj.org/article/7b4a8b2c7d344b0e9344d197a7338b0a
Autor:
Linda M. Liau, Keyoumars Ashkan, David D. Tran, Jian L. Campian, John E. Trusheim, Charles S. Cobbs, Jason A. Heth, Michael Salacz, Sarah Taylor, Stacy D. D’Andre, Fabio M. Iwamoto, Edward J. Dropcho, Yaron A. Moshel, Kevin A. Walter, Clement P. Pillainayagam, Robert Aiken, Rekha Chaudhary, Samuel A. Goldlust, Daniela A. Bota, Paul Duic, Jai Grewal, Heinrich Elinzano, Steven A. Toms, Kevin O. Lillehei, Tom Mikkelsen, Tobias Walbert, Steven R. Abram, Andrew J. Brenner, Steven Brem, Matthew G. Ewend, Simon Khagi, Jana Portnow, Lyndon J. Kim, William G. Loudon, Reid C. Thompson, David E. Avigan, Karen L. Fink, Francois J. Geoffroy, Scott Lindhorst, Jose Lutzky, Andrew E. Sloan, Gabriele Schackert, Dietmar Krex, Hans-Jorg Meisel, Julian Wu, Raphael P. Davis, Christopher Duma, Arnold B. Etame, David Mathieu, Santosh Kesari, David Piccioni, Manfred Westphal, David S. Baskin, Pamela Z. New, Michel Lacroix, Sven-Axel May, Timothy J. Pluard, Victor Tse, Richard M. Green, John L. Villano, Michael Pearlman, Kevin Petrecca, Michael Schulder, Lynne P. Taylor, Anthony E. Maida, Robert M. Prins, Timothy F. Cloughesy, Paul Mulholland, Marnix L. Bosch
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-2 (2018)
Following publication of the original article [1], the authors reported an error in the spelling of one of the author names. In this Correction the incorrect and correct author names are indicated and the author name has been updated in the original
Externí odkaz:
https://doaj.org/article/523386e861dd4740aa938b4e7fa9768c
Autor:
Samuel Goldlust, Tom Mikkelsen, Reid C. Thompson, David Avigan, John E. Trusheim, Marnix L. Bosch, Kevin Petrecca, David S. Baskin, David Mathieu, Sarah A. Taylor, Timothy F. Cloughesy, Jian Campian, Raphael P. Davis, Christopher Duma, Lyndon Kim, Robert M. Prins, Kevin A. Walter, Keyoumars Ashkan, Scott Lindhorst, Tobias Walbert, Andrew E. Sloan, John L. Villano, Daniela A. Bota, Simon Khagi, Santosh Kesari, David Piccioni, Michael Salacz, Manfred Westphal, Steven A. Toms, Jose Lutzky, Dietmar Krex, Linda M. Liau, Timothy J. Pluard, Paul Duic, Richard M. Green, Rekha Chaudhary, Clement Pillainayagam, Andrew Brenner, Fabio M. Iwamoto, Steven Brem, Heinrich Elinzano, Edward J. Dropcho, Karen Fink, Hans Jorg Meisel, Michael Pearlman, Michel Lacroix, Jason Heth, Julian Wu, Lynne Taylor, Kevin O. Lillehei, Stacy D. D’Andre, Pamela Z. New, Gabriele Schackert, Arnold B. Etame, David Tran, Steven R. Abram, Jai Grewal, Paul Mulholland, William G. Loudon, Sven Axel May, Francois J. Geoffroy, Victor Tse, Robert Aiken, Matthew G. Ewend, Anthony E. Maida, Michael Schulder, Jana Portnow, Charles S. Cobbs, Yaron A. Moshel
Publikováno v:
Liau, Linda M; Ashkan, Keyoumars; Tran, David D; Campian, Jian L; Trusheim, John E; Cobbs, Charles S; et al.(2018). Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.. Journal of translational medicine, 16(1), 179. doi: 10.1186/s12967-018-1552-1. UC Office of the President: Research Grants Program Office (RGPO). Retrieved from: http://www.escholarship.org/uc/item/1k3480p0
Journal of Translational Medicine
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-2 (2018)
Journal of Translational Medicine
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-2 (2018)
Background Standard therapy for glioblastoma includes surgery, radiotherapy, and temozolomide. This Phase 3 trial evaluates the addition of an autologous tumor lysate-pulsed dendritic cell vaccine (DCVax®-L) to standard therapy for newly diagnosed g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c249b32746a18134ef143a85ab82d24
http://www.escholarship.org/uc/item/1k3480p0
http://www.escholarship.org/uc/item/1k3480p0
Autor:
Manfred Westphal, Dietmar Krex, Rekha Chaudhary, Christopher Duma, Jana Portnow, Tom Mikkelsen, Reid C. Thompson, Edward J. Dropcho, Charles S. Cobbs, Sven-Axel May, Santosh Kesari, Michel Lacroix, Raphael P. Davis, David Avigan, Robert M. Prins, Jian Campian, Keyoumars Ashkan, John L. Villano, Yaron A. Moshel, John E. Trusheim, David Piccioni, Timothy J. Pluard, Paul Duic, Timothy F. Cloughesy, Michael Salacz, Andrew Brenner, Daniela A. Bota, Stacy D. D’Andre, Jai Grewal, Victor Tse, Steven A. Toms, Jason Heth, Lyndon Kim, Clement Pillainayagam, David S. Baskin, David Tran, Kevin A. Walter, Steven R. Abram, Andrew E. Sloan, Richard M. Green, Julian Wu, Scott Lindhorst, Simon Khagi, Heinrich Elinzano, Matthew G. Ewend, Paul Mulholland, Fabio M. Iwamoto, Anthony E. Maida, Michael Schulder, Kevin O. Lillehei, Karen Fink, Robert Aiken, Lynne Taylor, Hans-Jorg Meisel, William G. Loudon, Arnold B. Etame, Francois J. Geoffroy, Sarah A. Taylor, Pamela Z. New, Steven Brem, Gabriele Schackert, David Mathieu, Marnix L. Bosch, Tobias Walbert, Linda M. Liau, Michael Pearlman, Kevin Petrecca, Samuel Goldlust, Jose Lutzky
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-9 (2018)
Liau, Linda M; Ashkan, Keyoumars; Tran, David D; Campian, Jian L; Trusheim, John E; Cobbs, Charles S; et al.(2018). First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.. Journal of translational medicine, 16(1), 142. doi: 10.1186/s12967-018-1507-6. UC Office of the President: Research Grants Program Office (RGPO). Retrieved from: http://www.escholarship.org/uc/item/4zs134n7
Journal of Translational Medicine
Liau, Linda M; Ashkan, Keyoumars; Tran, David D; Campian, Jian L; Trusheim, John E; Cobbs, Charles S; et al.(2018). First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.. Journal of translational medicine, 16(1), 142. doi: 10.1186/s12967-018-1507-6. UC Office of the President: Research Grants Program Office (RGPO). Retrieved from: http://www.escholarship.org/uc/item/4zs134n7
Journal of Translational Medicine
Background Standard therapy for glioblastoma includes surgery, radiotherapy, and temozolomide. This Phase 3 trial evaluates the addition of an autologous tumor lysate-pulsed dendritic cell vaccine (DCVax®-L) to standard therapy for newly diagnosed g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7eee1a79d20bdb89286ba57579f8eecf
Publikováno v:
Bron, J L, Helder, M N, Meisel, H J, van Royen, B J & Smit, T H 2009, ' Repair, regenerative and supportive therapies of the annulus fibrosus: achievements and challenges ', European Spine Journal, vol. 18, no. 3, pp. 301-313 . https://doi.org/10.1007/s00586-008-0856-x
European Spine Journal
European Spine Journal, 18(3), 301-313. Springer Verlag
European Spine Journal
European Spine Journal, 18(3), 301-313. Springer Verlag
Lumbar discectomy is a very effective therapy for neurological decompression in patients suffering from sciatica due to hernia nuclei pulposus. However, high recurrence rates and persisting post-operative low back pain in these patients require serio
Autor:
David Greg Anderson, Alexander R. Vaccaro, Hans-Jorg Meisel, Makarand V. Risbud, Irving M. Shapiro, John K. Fraser, Todd J. Albert, Paul I. J. M. Wuisman, Chadi Tannoury
Publikováno v:
Spine, 30(17 Suppl), S14-S19. Lippincott Williams and Wilkins
Anderson, D G, Albert, T J, Fraser, J K, Risbud, M, Wuisman, P I J M, Meisel, H J, Tannoury, C, Shapiro, I & Vaccaro, A R 2005, ' Cellular therapy for disc degeneration ', Spine, vol. 30, no. 17 Suppl, pp. S14-S19 . https://doi.org/10.1097/01.brs.0000175174.50235.ba
Anderson, D G, Albert, T J, Fraser, J K, Risbud, M, Wuisman, P I J M, Meisel, H J, Tannoury, C, Shapiro, I & Vaccaro, A R 2005, ' Cellular therapy for disc degeneration ', Spine, vol. 30, no. 17 Suppl, pp. S14-S19 . https://doi.org/10.1097/01.brs.0000175174.50235.ba
Summary of Background Data. Disc degeneration is asubstantial clinical problem. Disc degeneration beginswith a loss of disc cells and alterations in the extracellularmatrix of the disc. One promising approach for this prob-lem involves the use of cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50530eb754e2871ca455df93164ecf5f
https://research.vumc.nl/en/publications/24743c97-cce4-49ee-ad58-6cc095dd547d
https://research.vumc.nl/en/publications/24743c97-cce4-49ee-ad58-6cc095dd547d
Autor:
Peter Schwenkreis, Andreas Gonschorek, Florian Berg, Ullrich Meier, Witold Rogge, Ingo Schmehl, Bodo Christian Kern, Hans-Jörg Meisel, Kai Wohlfarth, Stefan Gross, Matthias Sczesny-Kaiser, Martin Tegenthoff, Jürgen Boschert, Ralf Bruckmoser, Andrea Fürst, Marc Schaan, Martin Strowitzki, Andreas Pingel, Lisa Linnea Jägers, Henrik Rudolf, Hans-Joachim Trampisch, Johannes Lemcke
Publikováno v:
BMJ Open, Vol 11, Iss 6 (2021)
Objectives Since 2000/2001, no large-scale prospective studies addressing traumatic brain injury (TBI) epidemiology in Germany have been published. Our aim was to look for a possible shift in TBI epidemiology described in other European countries, to
Externí odkaz:
https://doaj.org/article/4c943645b0a94b109c6adf254d52c1df